<!DOCTYPE html SYSTEM "about:legacy-compat">
<html class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>DC Code - </title>
    <meta property="st:title" content=""/>
    <meta name="description" content="A simple, free browser for the Washington, DC Code"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/reset.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/site.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/body.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <link rel="stylesheet" type="text/css" href="/css/icons/style.css" media="screen"/>
    <script type="text/javascript">
            var _paq = _paq || [];
            _paq.push(['trackPageView']);
            _paq.push(['enableLinkTracking']);
            (function() {
              var u="//analytics.code.dccouncil.us/";
              _paq.push(['setTrackerUrl', u+'piwik.php']);
              _paq.push(['setSiteId', 1]);
              var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
              g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
            })();

          window.searchHost = 'https://search.code.dccouncil.us';
          window.queryUrl = '/v1/search';
          </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <section class="container">
        <div class="right no-print search" id="search"> </div>
        <h1 id="sitename">
          <a href="/dc/council/laws/21-131.html">D.C. Law 21-131. Revised Synthetics Abatement and Full Enforcement Drug Control Temporary Amendment Act of 2016.</a>
        </h1>
      </section>
    </header>
    <main class="main container">
      <div class="clearfix" style="width: 100%;">
        <aside id="sidebar" class="col4 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li>↪ <a href="/">D.C. Law Library</a></li>
            <li>↪ <a href="/dclaws/">D.C. Laws</a></li>
            <li>↪ <a href="/dclaws/21/">Council Period 21</a></li>
            <li>↪ D.C. Law 21-131. Revised Synthetics Abatement and Full Enforcement Drug Control Temporary Amendment Act of 2016.</li>
          </ul>
          <h2>Law Information</h2>
          <dl>
            <dt>Cites</dt>
            <dd>D.C. Law 21-131 (<a class="internal-link" href="http://lims.dccouncil.us/Download/35387/B21-0634-SignedAct.pdf">PDF</a>)<br/>63 DCR 7110<br/></dd>
            <dt>Effective</dt>
            <dd>July 1, 2016</dd>
            <dt>Legislative History</dt>
          </dl>
          <section class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/laws/21-131.html">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/laws/21-131.html">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </section>
        </aside>
        <section class="col8 body"><h1>D.C. Law 21-131. Revised Synthetics Abatement and Full Enforcement Drug Control Temporary Amendment Act of 2016.</h1> <section class="content"><p style="text-align: center;">AN ACT</p><p style="font-style: italic">To amend, on a temporary basis, the District of Columbia Uniform Controlled Substances Act of 1981 to add certain classes and substances to the list of Schedule I controlled substances.</p><p class="text-indent-1">BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Revised Synthetics Abatement and Full Enforcement Drug Control Temporary Amendment Act of 2016".</p><p class="text-indent-1"><span class="level-num">Sec. 2. </span>The District of Columbia Uniform Controlled Substances Act of 1981, effective August 5, 1981 (D.C. Law 4-29; D.C. Official Code § 48-901.01 et seq.), is amended as follows:</p><p class="text-indent-1"><span class="level-num">(a)</span> Section 102 (27) (D.C. Official Code § 48-901.02(27)) is amended as follows:</p><p class="text-indent-1">Strike the phrase "as used in section 204(3) and section 206(1)(D)" and insert the phrase "as used in section 204(3), (5), and (6) and section 206(1)(D)" in its place.</p><p class="text-indent-2"><span class="level-num">(2)</span> Strike the phrase "As used in section 204(3)" and insert the phrase "As used in section 204(3), (5), and (6)" in its place.</p><p class="text-indent-1"><span class="level-num">(b)</span> Section 204 (D.C. Official Code § 48-902.04) is amended as follows:</p><p class="text-indent-2"><span class="level-num">(1)</span> Paragraph (3) is amended as follows:</p><p class="text-indent-3"><span class="level-num">(A)</span> The lead-in language is amended by striking the phrase "(for purposes of this paragraph only, the term "isomer" includes the optical, position, and geometric isomers)".</p><p class="text-indent-3"><span class="level-num">(B)</span> New subparagraphs (G-i) through (G-xii) are added to read as follows:</p><p class="text-indent-4">"<span class="level-num">(G-ii)</span> 25B-NBOMe (also known as 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine);</p><p class="text-indent-4">"<span class="level-num">(G-iii)</span> 25C-NBOMe (also known as 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine);</p><p class="text-indent-4">"<span class="level-num">(G-iv)</span> 5-APB (also known as 1-(benzofuran-5-yl)propan-2-amine);</p><p class="text-indent-4">"<span class="level-num">(G-v)</span> 5-APDB (also known as 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine);</p><p class="text-indent-4">"<span class="level-num">(G-vi)</span> 6-APB (also known as 1-(1-benzofuran-6-yl)propan-2-amine);</p><p class="text-indent-4">"<span class="level-num">(G-vii)</span> 6-APDB (also known as1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine);</p><p class="text-indent-4">"<span class="level-num">(G-viii)</span> 3-methoxy-PCE (also known as N-ethyl-1-(3-methoxyphenyl)cyclohexanamine);</p><p class="text-indent-4">"<span class="level-num">(G-ix)</span> 3-methoxy-PCP (also known as 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine);</p><p class="text-indent-4">"<span class="level-num">(G-x)</span> 4-methoxy-PCP (also known as 1-[1-(4-methoxyphenyl)cyclohexyl]piperidine);</p><p class="text-indent-4">"<span class="level-num">(G-xi)</span> 5-MeO-DALT (also known as N,N-diallyl-5-methoxytryptamine);</p><p class="text-indent-4">"<span class="level-num">(G-xii)</span> 4-AcO-DMT (also known as 5-acetoxy-N,N-dimethyltryptamine);".</p><p class="text-indent-3"><span class="level-num">(C)</span> A new subparagraph (M-i) is added to read as follows:</p><p class="text-indent-2"><span class="level-num">(D)</span> Subparagraph (JJ) is amended by striking the word "and".</p><p class="text-indent-2"><span class="level-num">(E)</span> Subparagraph (KK) is amended by striking the phrase "(2C-P);" and inserting the phrase "(2C-P); and" in its place.</p><p class="text-indent-2"><span class="level-num">(F)</span> A new subparagraph (LL) is added to read as follows:</p><p class="text-indent-2"><span class="level-num">(2)</span> Paragraph (5) is repealed.</p><p class="text-indent-2"><span class="level-num">(3)</span> A new paragraph (5A) is added to read as follows:</p><p class="text-indent-4">"<span class="level-num">(A)</span> Classified Synthetic Cathinones:</p><p class="text-indent-5">"<span class="level-num">(i)</span> Any compound containing a 2-amino-1-propanone structure with substitution at the 1-position with a monocyclic or fused polycyclic ring system and a substitution at the nitrogen atom by an alkyl group, cycloalkyl group, or incorporation into a heterocyclic structure. Examples of this structural class include:</p><p class="text-indent-6">"<span class="level-num">(I)</span> -pyrrolidinopropiophenone, also known as:</p><p class="text-indent-7">"<span class="level-num">(aa)</span> 1-phenyl-2-(1-pyrrolidinyl)-1-propanone; or</p><p class="text-indent-7">"<span class="level-num">(bb)</span> α-PPP;</p><p class="text-indent-6">"<span class="level-num">(II)</span> Dimethylcathinone, also known as:</p><p class="text-indent-7">"<span class="level-num">(aa)</span> 2-(dimethylamino)-1-phenyl-1-propanone; or</p><p class="text-indent-7">"<span class="level-num">(bb)</span> N,N-Dimethylcathinone; and</p><p class="text-indent-6">"<span class="level-num">(III)</span> Ethcathinone, also known as:</p><p class="text-indent-7">"<span class="level-num">(aa)</span> 2-(ethylamino)-1-phenyl-1-propanone;</p><p class="text-indent-7">"<span class="level-num">(bb)</span> Ethylcathinone;</p><p class="text-indent-7">"<span class="level-num">(cc)</span> N-Ethylcathinone; or</p><p class="text-indent-7">"<span class="level-num">(dd)</span> 2-Ethylaminobuphedro;</p><p class="text-indent-5">"<span class="level-num">(ii)</span> Any compound containing a 2-amino-1-propanone structure with substitution at the 1-position with a monocyclic or fused polycyclic ring system and a substitution at the 3-position carbon with an alkyl, haloalkyl, or alkoxy group. Examples of this structural class include naphyrone (also known as 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one);</p><p class="text-indent-5">"<span class="level-num">(iii)</span> Any compound containing a 2-amino-1-propanone structure with substitution at the 1-position with a monocyclic or fused polycyclic ring system and a substitution at any position of the ring system with an alkyl, haloalkyl, halogen, alkylenedioxy, or alkoxy group, whether or not further substituted at any position on the ring system to any extent. Examples of this structural class include:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 3-fluoromethylone;</p><p class="text-indent-6">"<span class="level-num">(II)</span> Mephedrone, also known as:</p><p class="text-indent-7">"<span class="level-num">(aa)</span> 2-(methylamino)-1-(4-methylphenyl)-1-propanone;</p><p class="text-indent-7">"<span class="level-num">(bb)</span> 4-MeMC;</p><p class="text-indent-7">"<span class="level-num">(cc)</span> 4-Methylmethcathinone;</p><p class="text-indent-7">"<span class="level-num">(dd)</span> 4-Methylephedrone; or</p><p class="text-indent-7">"<span class="level-num">(ee)</span> 4-MMC; and</p><p class="text-indent-6">"<span class="level-num">(III)</span> Methylone, also known as</p><p class="text-indent-7">"<span class="level-num">(aa)</span> 1-(1,3-benzodioxol-5-yl)-2-(methylamino)-1-propanone; or</p><p class="text-indent-7">"<span class="level-num">(bb)</span> 3,4-Methylenedioxy-N-methylcathinone);</p><p class="text-indent-5">"<span class="level-num">(iv)</span> Any compound containing or structurally derived from a piperazine, or diethylenediamine, structure with or without substitution at one of the nitrogen atoms of the piperazine ring to any extent. Examples include:</p><p class="text-indent-6">"<span class="level-num">(I)</span> BZP, also known as:</p><p class="text-indent-7">"<span class="level-num">(aa)</span> 1-(phenylmethyl)-piperazine;</p><p class="text-indent-7">"<span class="level-num">(bb)</span> 1-Benzylpiperazine; or</p><p class="text-indent-7">"<span class="level-num">(cc)</span> N-Benzylpiperazine; and</p><p class="text-indent-6">"<span class="level-num">(II)</span> TMFPP, also known as:</p><p class="text-indent-7">"<span class="level-num">(aa)</span> 1-[3-(trifluoromethyl)phenyl]-piperazine;</p><p class="text-indent-7">"<span class="level-num">(bb)</span> 1-(m-Trifluoromethylphenyl) piperazine; or</p><p class="text-indent-7">"<span class="level-num">(cc)</span> 3-Trifluoromethylphenylpiperazine;</p><p class="text-indent-4">"<span class="level-num">(B)</span> Unclassified Synthetic Cathinones:</p><p class="text-indent-5">"<span class="level-num">(i)</span> Aminorex (also known as (RS)-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine);</p><p class="text-indent-5">"<span class="level-num">(ii)</span> -ET, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> -ethyl-1H-indole-3-ethanamine;</p><p class="text-indent-6">"<span class="level-num">(II)</span> -ethyltryptamine; or</p><p class="text-indent-6">"<span class="level-num">(III)</span> 3-Indolybutylamine;</p><p class="text-indent-5">"<span class="level-num">(iii)</span> -MT, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> -methyl-1H-indole-3-ethanamine; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> -methyltryptamine;</p><p class="text-indent-5">"<span class="level-num">(iv)</span> α-PBP, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 1-phenyl-2-(1-pyrrolidinyl)-1-butanone; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> -pyrrolidinobutiophenone;</p><p class="text-indent-5">"<span class="level-num">(v)</span> α-PVP  (also known as α-pyrrolidinopentiophenone);</p><p class="text-indent-5">"<span class="level-num">(vi)</span> bk-MDDMA, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one;</p><p class="text-indent-6">"<span class="level-num">(II)</span> Dimethylone;</p><p class="text-indent-6">"<span class="level-num">(III)</span> N,N-dimethyl-3′,4′-methylenedioxycathinone;</p><p class="text-indent-6">"<span class="level-num">(IV)</span> N,N-dimethyl-3,4-methylenedioxycathinone; or</p><p class="text-indent-6">"<span class="level-num">(V)</span> N,N-Dimethyl MDCATH;</p><p class="text-indent-5">"<span class="level-num">(vii)</span> Buphedrone, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 2-(methylamino)-1-phenylbutan-1-one; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> MABP;</p><p class="text-indent-5">"<span class="level-num">(viii)</span> Butylone (also known as 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one);</p><p class="text-indent-5">"<span class="level-num">(ix)</span> 3,4-DMMC, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 1-(3,4-dimethylphenyl)-2-(methylamino)-1-propanone;or</p><p class="text-indent-6">"<span class="level-num">(II)</span> 3,4-Dimethylmethcathinone;</p><p class="text-indent-5">"<span class="level-num">(x)</span> EMA, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> N-ethyl-α-methyl-benzeneethanamine; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> N-Ethylamphetamine;</p><p class="text-indent-5">"<span class="level-num">(xi)</span> EMC, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 1-(4-ethylphenyl)-2-(methylamino)propan-1-one;</p><p class="text-indent-6">"<span class="level-num">(II)</span> 4-EMC; or</p><p class="text-indent-6">"<span class="level-num">(III)</span> 4-Ethylmethcathinone;</p><p class="text-indent-5">"<span class="level-num">(xii)</span> Ethylone, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 3,4-Methylenedioxy-N-ethylcathinone; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> MDEC;</p><p class="text-indent-5">"<span class="level-num">(xiii)</span> Fenethylline (also known as (RS)-1,3-dimethyl- 7-[2-(1-bpphenylpropan-2-ylamino)ethyl]purine-2,6-dione);</p><p class="text-indent-5">"<span class="level-num">(xiv)</span> Fluoromethcathinone (also known as 1-(4-fluorophenyl)-2-(methylamino) propan-1-one);</p><p class="text-indent-5">"<span class="level-num">(xv)</span> 3-FMC (also known as 3-fluoro-N-methylcathinone);</p><p class="text-indent-5">"<span class="level-num">(xvi)</span> 4-FMC, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 1-(4-fluorophenyl)-2-(methylamino)propan-1-one;</p><p class="text-indent-6">"<span class="level-num">(II)</span> 4-fluoro-N-methylcathinone; or</p><p class="text-indent-6">"<span class="level-num">(III)</span> Flephedrone;</p><p class="text-indent-4">"<span class="level-num">(xvii)</span> MDPBP, also known as:</p><p class="text-indent-5">"<span class="level-num">(I)</span> 1-(1,3-benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-butanone; or</p><p class="text-indent-5">"<span class="level-num">(II)</span> 3,4-Methylenedioxy-α-Pyrrolidinobutiophenone;</p><p class="text-indent-5">"<span class="level-num">(xviii)</span> MDPPP, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 1-(1,3-benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-propanone; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> 3,4-Methylenedioxy-α-Pyrrolidinopropiophenone;</p><p class="text-indent-5">"<span class="level-num">(xix)</span> MDPV, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 1-(1,3-benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> 3,4-Methylenedioxy Pyrovalerone;</p><p class="text-indent-5">"<span class="level-num">(xx)</span> 4-MeBP, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 2-(methylamino)-1-(4-methylphenyl)-1-butanone;</p><p class="text-indent-6">"<span class="level-num">(II)</span> 4-Methylbuphedrone;</p><p class="text-indent-6">"<span class="level-num">(III)</span> 4-methyl BP; or</p><p class="text-indent-6">"<span class="level-num">(IV)</span> 4-MeMABP</p><p class="text-indent-5">"<span class="level-num">(xxi)</span> 3-MEC, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 2-(ethylamino)-1-(m-tolyl)propan-1-one; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> 3-Methyl-N-ethylcathinone;</p><p class="text-indent-5">"<span class="level-num">(xxii)</span> 4-MEC, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 2-(ethylamino)-1-(4-methylphenyl)-1-propanone; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> 4-Methyl-N-ethylcathinone;</p><p class="text-indent-5">"<span class="level-num">(xxiii)</span> 4-MePPP, also known as</p><p class="text-indent-6">"<span class="level-num">(I)</span> 4'-methyl-α-Pyrrolidinopropiophenone;</p><p class="text-indent-6">"<span class="level-num">(II)</span> 4'-methyl PPP; or</p><p class="text-indent-6">"<span class="level-num">(III)</span> 2-(pyrrolidin-1-yl)-1-(p-tolyl)propan-1-one;</p><p class="text-indent-5">"<span class="level-num">(xxiv)</span> 3-MMC, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 2-(methylamino)-1-(3-methylphenyl)-1-propanone;</p><p class="text-indent-6">"<span class="level-num">(II)</span> 3-methyl MS; or</p><p class="text-indent-6">"<span class="level-num">(III)</span> 3-Methylmethcathinone;</p><p class="text-indent-5">"<span class="level-num">(xxv)</span> Methedrone (also known as 1-(4-methoxyphenyl)-2-(methylamino)-1-propanone);</p><p class="text-indent-5">"<span class="level-num">(xxvi)</span> 4′-methyl PHP, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 4′-methyl-α-pyrrolidinohexanophenone;</p><p class="text-indent-6">"<span class="level-num">(II)</span> MPHP;</p><p class="text-indent-6">"<span class="level-num">(III)</span> 4'-methyl- α-PHP; or</p><p class="text-indent-6">"<span class="level-num">(IV)</span> PV4;</p><p class="text-indent-5">"<span class="level-num">(xxvii)</span> Naphyrone, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> 1-(2-naphthalenyl)-2-(1-pyrrolidinyl)-1-pentanone; or</p><p class="text-indent-6">"<span class="level-num">(II)</span> Naphpyrovalerone;</p><p class="text-indent-5">"<span class="level-num">(xxviii)</span> N-hydroxy MDA, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> MDOH;</p><p class="text-indent-6">"<span class="level-num">(I)</span> N-hydroxy-α-methyl-1,3-benzodioxole-5-ethanamine;or</p><p class="text-indent-6">"<span class="level-num">(II)</span> N-Hydroxy-3,4-methylenedioxyamphetamine;</p><p class="text-indent-5">"<span class="level-num">(xxix)</span> N,N-DMA, also known as:</p><p class="text-indent-6">"<span class="level-num">(I)</span> N,N,α-trimethyl-benzeethanamine;</p><p class="text-indent-6">"<span class="level-num">(II)</span> N,N-Dimethylamphetamine;</p><p class="text-indent-6">"<span class="level-num">(III)</span> Dimetamfetamine; or</p><p class="text-indent-6">"<span class="level-num">(III)</span> Metrotonin;</p><p class="text-indent-5">"<span class="level-num">(xxx)</span> Pentedrone (also known as 2-(methylamino)-1-phenylpentan-1-one); and</p><p class="text-indent-5">"<span class="level-num">(xxxi)</span> Pentylone (also known as 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one);".</p><p class="text-indent-1"><span class="level-num">(4)</span> A new paragraph (6) is added to read as follows:</p><p class="text-indent-3">"<span class="level-num">(A)</span> Classified Synthetic Cannabimimetic Agents:</p><p class="text-indent-2">"<span class="level-num">(i)</span> Adamantanoylindoles: Any compound containing or structurally derived from an adamantanyl-(1H-indol-3-yl)methanone structure with or without substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent.  Examples include:</p><p class="text-indent-3">"<span class="level-num">(I)</span> AB-001, also known as:</p><p class="text-indent-4">"<span class="level-num">(aa)</span> (1s,3s)-adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone; or</p><p class="text-indent-4">"<span class="level-num">(bb)</span> JWH 018 adamantyl analog; and</p><p class="text-indent-5">"<span class="level-num">(II)</span> AM-1248, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]tricyclo[3.3.1.13,7]dec-1-yl-methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> AM1248;</p><p class="text-indent-4">"<span class="level-num">(ii)</span> Adamantoylindazoles: or any compound containing or structurally derived from 3-(1-adamantoyl) indole, 3-(1-adamantoyl)indazole, 3-(2-adamantoyl)indole, N-(1-adamantyl)-1H-indole-3-carboxamide, or N-(1-adamantyl)-1H-indazole-3-carboxamide by substitution at the nitrogen atom of the indole or indazole ring with alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole or indazole ring to any extent and whether or not substituted in the adamantyl ring to any extent.  This category includes adamantyl carboxamide indazoles;</p><p class="text-indent-4">"<span class="level-num">(iii)</span> Adamantylamidoindoles: Any compound containing or structurally  derived from  an N-(adamantyl)-indole-3-carboxamide structure, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent;</p><p class="text-indent-4">"<span class="level-num">(iv)</span> Adamantylindazoles: Any compound containing or structurally derived from an N-(adamantyl)-indazole-3-carboxamide structure with substitution at a nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent, whether or not substituted on the adamantyl ring to any extent.  Examples include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> 5F-APINACA, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 5-fluoro-APINACA</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 5F-AKB-48;</p><p class="text-indent-6">"<span class="level-num">(cc)</span> 5F-AKB48;</p><p class="text-indent-6">"<span class="level-num">(dd)</span> N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide; or</p><p class="text-indent-6">"<span class="level-num">(ee)</span> N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide); and</p><p class="text-indent-5">"<span class="level-num">(II)</span> APINACA, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> AKB-48;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> AKB48;</p><p class="text-indent-6">"<span class="level-num">(cc)</span> 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide; or</p><p class="text-indent-6">"<span class="level-num">(dd)</span> N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide;</p><p class="text-indent-4">"<span class="level-num">(v)</span> Adamantylindoles:  Any compound containing or structurally derived from an N-(adamantyl)-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, and whether or not substituted on the adamantyl ring to any extent.  Examples include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> 2NE1, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> APICA;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> JWH 018 adamantyl carboxamide; or</p><p class="text-indent-6">"<span class="level-num">(cc)</span> 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide;</p><p class="text-indent-5">"<span class="level-num">(II)</span> Adamantyl carboxamide indoles; and</p><p class="text-indent-5">"<span class="level-num">(III)</span> STS-135, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> N-adamantyl-1-fluoropentylindole-3-Carboxamide;</p><p class="text-indent-6">"<span class="level-num">(cc)</span> 5F-APICA; or</p><p class="text-indent-6">"<span class="level-num">(dd)</span> 5-fluoro-APICA;</p><p class="text-indent-4">"<span class="level-num">(vi)</span> Benzimidazole Ketone: Any compound containing or structurally derived from (benzimidazole-2-yl) methanone structure with or without substitution at either nitrogen atom of the benzimidazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, with substitution at the carbon of the methanone group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3, 3-dimethyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3, 3-dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not further substituted in the benzimidazole, adamantyl, naphthyl, phenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent.  Benzimidazole Ketones include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> FUBIMINA, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> AM2201 benzimidazole analog; and</p><p class="text-indent-5">"<span class="level-num">(II)</span> JWH-018 benzimidazole analog, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> naphthalen-1-yl(1-pentyl-1H-benzo[d]imidazol-2-yl)methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> BIM-018;</p><p class="text-indent-4">"<span class="level-num">(vii)</span> Benzoylindoles: Any compound containing or structurally derived from a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.  Examples include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> AM-630, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> [6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)-methanone;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> AM630; or</p><p class="text-indent-6">"<span class="level-num">(cc)</span> Iodopravadoline ;</p><p class="text-indent-5">"<span class="level-num">(II)</span> AM-661 (also known as 1-(N-methyl-2-piperidine)methyl-2-methyl-3-(2-iodo)benzoylindole);</p><p class="text-indent-5">"<span class="level-num">(III)</span> AM-679, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span><span class="level-num">(2-iodophenyl)</span><span class="level-num">(1-pentyl-1H-indol-3yl)</span> methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> AM679;</p><p class="text-indent-5">"<span class="level-num">(IV)</span> AM-694, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> [1-(5-fluoropentyl)-1H-indol-3-yl](2-iodophenyl)-methanone;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole;or</p><p class="text-indent-6">"<span class="level-num">(cc)</span> AM694;</p><p class="text-indent-5">"<span class="level-num">(V)</span> AM-1241, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span><span class="level-num">(2-iodo-5-nitrophenyl)</span> -(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> AM1241;</p><p class="text-indent-5">"<span class="level-num">(VI)</span> AM-2233, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span><span class="level-num">(2-iodophenyl)</span> [1-[(1-methyl-2piperidinyl)methyl]-1H-indol-3-yl]-methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> AM2233;</p><p class="text-indent-5">"<span class="level-num">(VII)</span> RCS-4, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span><span class="level-num">(4-methoxyphenyl)</span><span class="level-num">(1-pentyl-1H-indol-3-yl)</span> methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> SR-19; and</p><p class="text-indent-5">"<span class="level-num">(VIII)</span> WIN 48,098, also known as</p><p class="text-indent-6">"<span class="level-num">(aa)</span><span class="level-num">(4-methoxyphenyl)</span> [2-methyl]-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> "Pravadoline";</p><p class="text-indent-4">"<span class="level-num">(viii)</span> Carbazole Ketone: Any compound containing or structurally derived from (9H-carbazole-3-yl) methanone structure with or without substitution at the nitrogen atom of the carbazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group with substitution at the carbon of the methanone group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3, 3-dimethyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3, 3-dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not further substituted at the carbazole, adamantyl, naphthyl, phenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent. Carbazole Ketones include naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone ("EG-018");</p><p class="text-indent-4">"<span class="level-num">(ix)</span> Carboxamideindazoles: Any compound containing or structurally derived from 3-carboxamide-1H-indazoles, whether or not substituted in the indazole ring to any extent and substituted to any degree on the carboxamide nitrogen and 3-carboxamide-1H-indoles, whether or not substituted in the indole ring to any extent and substituted to any degree on the carboxamide nitrogen. Examples include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> AB-CHMINACA (also known as N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);</p><p class="text-indent-5">"<span class="level-num">(II)</span> AB-FUBINACA (also known as N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide);</p><p class="text-indent-5">"<span class="level-num">(III)</span> AB-PINACA (also known as N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide);</p><p class="text-indent-5">"<span class="level-num">(IV)</span> 5F AB-PINACA, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide); or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 5-fluoro AB-PINACA;</p><p class="text-indent-5">"<span class="level-num">(V)</span> ADB-FUBINACA (also known as N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1-H-indazole-3-carboxamide);</p><p class="text-indent-5">"<span class="level-num">(VI)</span> ADB-PINACA (also known as N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide);</p><p class="text-indent-5">"<span class="level-num">(VII)</span> 5F ADB-PINACA, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1(5-fluoropentyl)-1H-indazole-3-carboxamide); or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 5-fluoro ADB-PINACA;</p><p class="text-indent-5">"<span class="level-num">(VIII)</span> FUB-AMB, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> AMB-FUBINACA;</p><p class="text-indent-5">"<span class="level-num">(IX)</span> MAB-CHMINACA (also known as N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);</p><p class="text-indent-5">"<span class="level-num">(X)</span> MMB CHMINACA, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> methyl (S)-2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> MDMB-CHMICA; and</p><p class="text-indent-5">"<span class="level-num">(XI)</span> 5F MN-18, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 1-(5-fluoropentyl)-N-1-naphthalenyl-1H-indazole-3-carboxamide; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 5-fluoro MN-18;</p><p class="text-indent-4">"<span class="level-num">(x)</span> Cycloalkanemethanone Indoles: whether or not substituted at the nitrogen atom on the indole ring, whether or not further substituted in the indole ring to any extent, and whether or not substituted on the cycloalkane ring to any extent;</p><p class="text-indent-4">"<span class="level-num">(xi)</span> Cyclohexylphenols: Any compound containing or structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the cyclohexyl ring to any extent.  Examples include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> CP 47,497 (also known as 2-[(1S,3R)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl)phenol);</p><p class="text-indent-5">"<span class="level-num">(II)</span> CP 47,497 C8 homologue, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> rel-2-[(1S,3R)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> Cannabicyclohexanol;</p><p class="text-indent-5">"<span class="level-num">(III)</span> CP 55,490;</p><p class="text-indent-5">"<span class="level-num">(IV)</span> CP 55,940 (also known as 5-(1,1-dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-phenol); and</p><p class="text-indent-5">"<span class="level-num">(V)</span> CP 56,667;</p><p class="text-indent-4">"<span class="level-num">(xii)</span> Cyclopropanoylindoles: Any compound containing or structurally derived from 3-(cyclopropylmethanoyl)indole, 3-(cyclopropylmethanone)indole, 3-(cyclobutylmethanone)indole or 3-(cyclopentylmethanone)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, and whether or not substituted on the cyclopropyl, cyclobutyl, or cyclopentyl rings to any extent;</p><p class="text-indent-4">"<span class="level-num">(xiii)</span> Cyclopropylmethanone Indole: Any compound containing or structurally derived from 3-Cyclopropylmethanone indole or 3-Cyclobutylmethanone indole or 3-Cyclopentylmethanone indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent andwhether or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl rings to any extent;</p><p class="text-indent-4">"<span class="level-num">(xiv)</span> Hexahydrodibenzopyrans: Any compound containing or structurally derived from Hexahydrodibenzopyrans, whether or not substituted in the tricyclic ring system except where contained in cannabis or cannabis resin;</p><p class="text-indent-4">"<span class="level-num">(xv)</span> Hydroxycyclohexylphenol: Any compound containing or structurally derived from 2-(3-hydroxycyclohexyl)phenol structure, also known as cyclohexylphenols, with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted on the cyclohexyl ring to any extent. Examples of this structural class include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> CP-47,497 (also known as rel-5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol);</p><p class="text-indent-5">"<span class="level-num">(II)</span> CP 47,497-C8-homolog, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> rel-2-[(1S,3R)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> cannabicyclohexanol; and</p><p class="text-indent-5">"<span class="level-num">(III)</span> CP-55,940 (also known as 2-((1S,2S,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2-methyloctan-2-yl)phenol);</p><p class="text-indent-4">"<span class="level-num">(xvi)</span> Indazole Ester (also known as carboxylateindazole): Any compound containing or structurally derived from 3-carboxylate-indazoles, whether or not substituted in the indazole ring to any extent or substituted to any degree on the carboxylate, whether or not substituted in the indazole ring to any extent and substituted to any degree on the carboxylate oxygen. Examples of indazole esters include 5-fluoro SDB-005, also known as:</p><p class="text-indent-5">"<span class="level-num">(I)</span> naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate; or</p><p class="text-indent-5">"<span class="level-num">(II)</span> 5F SDB-005;</p><p class="text-indent-4">"<span class="level-num">(xvii)</span> Indole Amides: Any compound containing or structurally derived from or containing a 1H-Indole-3-carboxamide structure with or without substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not substituted at the carboxamide group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3, 3-dimethyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3, 3-dimethyl-1-oxobutan-2-yl or pyrrole group and whether or not further substituted in the indole, adamantyl, naphthyl, phenyl, pyrrole, quninolinyl, or cycloalkyl rings to any extent. Indole Amides include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> 5F ABICA, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span><span class="level-num">(S)</span> -N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide; or</p><p class="text-indent-6">"<span class="level-num">(cc)</span> 5-fluoro ABICA;</p><p class="text-indent-5">"<span class="level-num">(II)</span> ADBICA (also known as N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide));</p><p class="text-indent-5">"<span class="level-num">(III)</span> 5F-ADBICA, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 5-fluoro-ADBICA;</p><p class="text-indent-5">"<span class="level-num">(IV)</span> NNE1 (also known as N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide);</p><p class="text-indent-5">"<span class="level-num">(V)</span> 5F-NNE1, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3-carboxamide); or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 5-fluoro-NNE1</p><p class="text-indent-5">"<span class="level-num">(VI)</span> SDB-006 (also known as N-benzyl-1-pentyl-1H-indole-3-carboxamide); and</p><p class="text-indent-5">"<span class="level-num">(VII)</span> 5F-SDB-006, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide); or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 5-fluoro-SDB-006;</p><p class="text-indent-4">"<span class="level-num">(xviii)</span> Indole Esters: Any compound containing or structurally derived from a 1H-Indole-3-carboxylate structure with or without substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not substituted at the carboxylate group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3, 3-dimethyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3, 3-dimethyl-1-oxobutan-2-yl or pyrrole group and whether or not further substituted in the indole, adamantyl, naphthyl, phenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent. Indole Esters may also be referred to as Quinolinylindolecarboxylates. Indole Esters include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> BB-22, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 1-(cyclohexylmethyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate; or</p><p class="text-indent-6">"<span class="level-num">(cc)</span> QUCHIC;</p><p class="text-indent-5">"<span class="level-num">(II)</span> FDU-PB-22  (also known as naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate);</p><p class="text-indent-5">"<span class="level-num">(III)</span> FUB-PB-22, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 8-quinolinyl ester; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> Quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate;</p><p class="text-indent-5">"<span class="level-num">(IV)</span> NM2201, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> CBL-2201;</p><p class="text-indent-5">"<span class="level-num">(V)</span> PB-22, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate;</p><p class="text-indent-6">"<span class="level-num">(cc)</span> 8-Quinolinyl 1-pentyl-1H-indole-3-carboxylate; or</p><p class="text-indent-6">"<span class="level-num">(dd)</span> "QUPIC"; and</p><p class="text-indent-5">"<span class="level-num">(VI)</span> 5F-PB-22, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate;</p><p class="text-indent-6">"<span class="level-num">(cc)</span> 8-Quinolinyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate;</p><p class="text-indent-6">"<span class="level-num">(dd)</span> 5-fluoro-PB-22; or</p><p class="text-indent-6">"<span class="level-num">(ee)</span> 5-fluoro QUPIC;</p><p class="text-indent-4">"<span class="level-num">(xix)</span> Naphthoylindoles: Any compound containing or structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl group, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the naphthyl ring to any extent. Napthoylindoles include the following: AM-678, AM-1220, AM-1221, AM-1235, AM-2232, EAM-2201, JWH-004, JWH-007, JWH-009, JWH-011, JWH-015, JWH-016, JWH-018, JWH-019, JWH-020, JWH-022, JWH-046, JWH-047, JWH-048, JWH-049, JWH-050, JWH-070, JWH-071, JWH-072, JWH-073, JWH-076, JWH-079, JWH-080, JWH-081, JWH-082, JWH-094, JWH-096, JWH-098, JWH-116, JWH-120, JWH-122, JWH-148, JWH-149, JWH-164, JWH-166, JWH-180, JWH-181, JWH-182, JWH-189, JWH-193, JWH-198, JWH-200, JWH-210, JWH-211, JWH-212, JWH-213, JWH-234, JWH-235, JWH-236, JWH-239, JWH-240, JWH-241, JWH-242, JWH-258, JWH-262, JWH-386, JWH-387, JWH-394, JWH-395, JWH-397, JWH-398, JWH-399, JWH-400, JWH-412, JWH-413, JWH-414, JWH-415, JWH-424, MAM-2201, WIN 55,212. Napthoylindoles also include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> AM-2201 (also known as (1-(5-fluoropentyl)-3-(1-naphthoyl)indole); and</p><p class="text-indent-5">"<span class="level-num">(II)</span> WIN 55,212-2, also known as: *</p><p class="text-indent-6">"<span class="level-num">(aa)</span><span class="level-num">(R)</span> -(+)-[2,3-dihydro-5-methyl-3- (4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> [2,3-Dihydro-5-methyl- 3-(4-morpholinylmethyl)pyrrolo[(1,2,3-de)-1,4-benzoxazin-6-yl]-1-napthalenylmethanone);</p><p class="text-indent-4">"<span class="level-num">(xx)</span> Naphthoylnaphthalenes: Any compound containing or structurally derived from naphthalene-1-yl-(naphthalene-1-yl) methanone with substitutions on either of the naphthalene rings to any extent, including CB-13 (also known as 1-naphthalenyl[4-(pentylox)-1-naphthalenyl]-methanone or CRA-13);</p><p class="text-indent-4">"<span class="level-num">(xxi)</span> Naphthoylpyrroles: Any compound containing or structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including the following: JWH-030, JWH-031, JWH-145, JWH-146, JWH-147, JWH-150, JWH-156, JWH-243, JWH-244, JWH-245, JWH-246, JWH-292, JWH-293, JWH-307, JWH-308, JWH-309, JWH-346, JWH-348, JWH-363, JWH-364, JWH-365, JWH-367, JWH-368, JWH-369, JWH-370, JWH-371, JWH-373, JWH-392;</p><p class="text-indent-4">"<span class="level-num">(xxii)</span> Naphthylamidoindoles: Any compound containing or structurally derived from a N-(naphthyl)-indole-3-carboxamide structure, whether or not further substituted in the indole ring to any extent or whether or not substituted in the naphthyl ring to any extent;</p><p class="text-indent-4">"<span class="level-num">(xxiii)</span> Naphthylmethylindenes: Any compound containing or structurally derived from a 1-(1-naphthylmethylene)indene structure with or without substitution at the 3-position of the indene ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not further substituted on the indene group to any extent, and whether or not substituted on the naphthyl group to any extent. Naphthylmethylindenes include JWH-176 (also known as 1-[(E)-(3-pentyl-1H-inden-1-ylidene)methyl]-naphthalene or (1-(3-pentyl)-1H-inden-1-ylidene)methylnaphthalene);</p><p class="text-indent-4">"<span class="level-num">(xxiv)</span> Naphthylmethyl indoles: Any compound containing or structurally derived from 1H-indol-3-yl-(1-naphthyl)methane structure, also known as napthylme-thylindoles, with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent. Examples of this structural class include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> JWH-175 (also known as 3-(1-naphthalenylmethyl)-1-pentyl-1H-indole); and</p><p class="text-indent-5">"<span class="level-num">(II)</span> JWH-184 (also known as 3-[(4-methyl-1-naphthalenyl)methyl]-1-pentyl-1H-indole);</p><p class="text-indent-4">"<span class="level-num">(xxv)</span> Naphthylmethylindenes: Any compound containing or structurally derived from a naphthylideneindene structure or that is structurally derived from 1-(1-naphthylmethyl)indene with substitution at the 3-position of the indene ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.  Examples include JWH-171, JWH-176, and JWH-220;</p><p class="text-indent-4">"<span class="level-num">(xxvi)</span> Naphthylmethylindoles: Any compound containing or structurally derived from an H-indol-3-yl-(1-naphthyl) methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.  Examples include JWH-175, JWH-184, JWH-185, JWH-192, JWH-194, JWH-195, JWH-196, JWH-197, and JWH-199;</p><p class="text-indent-4">"<span class="level-num">(xxvii)</span> Phenylacetylindoles: Any compound containing or structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Examples include: JWH-167, JWH-201, JWH-202, JWH-203, JWH-204, JWH-205, JWH-206, JWH-207, JWH-208, JWH-209, JWH-237, JWH-248, JWH-249, JWH-250, JWH-251, JWH-253, JWH-302, JWH-303, JWH-304, JWH-305, JWH-306, JWH-311, JWH-312, JWH-313, JWH-314, JWH-315, JWH-316, RCS-8, SR-18, and Cannabipiperidiethanone (also known as 2-(2-methoxyphenyl)-1-[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-ethanone);</p><p class="text-indent-4">"<span class="level-num">(xxviii)</span> Quinolinoyl Pyrazole: Any compound containing or structurally derived from Quinolinoyl pyrazole carboxylate (also known as Quinolinyl fluoropentyl fluorophenyl pyrazole carboxylate);</p><p class="text-indent-4">"<span class="level-num">(xxix)</span> Quinolinyl Ester Indoles: Any compound containing or structurally derived from  Quinolinyl ester indoles, being any compound containing or structurally derived from 1H-indole-3carboxylic acid-8-quinolinyl ester, whether or not substituted in the indole ring to any extent or the quinolone ring to any extent;</p><p class="text-indent-4">"<span class="level-num">(xxx)</span> Tetrahydrobenzochromen: Any compound containing or structurally derived from (6aR,10aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol. Examples of this structural class include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> AM-087 (also known as (6aR,10aR)-3-(2-methyl-6-bromohex-2-yl)- 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol);</p><p class="text-indent-5">"<span class="level-num">(II)</span> AM-411 (also known as (6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol);</p><p class="text-indent-5">"<span class="level-num">(III)</span> HU-210, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 3-(1,1'-dimethylheptyl)-6aR,7,10,10aR-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- tetrahydrobenzo[c]chromen-1-ol;</p><p class="text-indent-6">"<span class="level-num">(cc)</span> 1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol;  or</p><p class="text-indent-6">"<span class="level-num">(dd)</span> 1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol;</p><p class="text-indent-5">"<span class="level-num">(IV)</span> HU-211, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 3-(1,1-dimethylheptyl)-6aS,7,10,10aS-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;</p><p class="text-indent-6">"<span class="level-num">(cc)</span> (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; or</p><p class="text-indent-6">"<span class="level-num">(dd)</span> "Dexanabinol";</p><p class="text-indent-5">"<span class="level-num">(V)</span> HU-243, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> (6aR,8S,9S,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-1-ol; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 3-dimethylheptyl-11-hydroxyhexahydrocannabinol;</p><p class="text-indent-5">"<span class="level-num">(VI)</span> JWH-051 (also known as (6aR,10aR)-6,6-dimethyl-3- (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-9-yl)methanol);</p><p class="text-indent-5">"<span class="level-num">(VII)</span> JWH-133  (also known as (6aR,10aR)-3-(1,1-Dimethylbutyl) -6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran); and</p><p class="text-indent-5">"<span class="level-num">(VIII)</span> JWH-359  (also known as (6aR,10aR)- 1-methoxy-6,6,9-trimethyl- 3-[(2R)-1,1,2-trimethylbutyl]- 6a,7,10,10a-tetrahydrobenzo[c]chromene);</p><p class="text-indent-4">"<span class="level-num">(xxxi)</span> Δ8 Tetrahydrocannabinol: Any compound containing or structurally derived from 11-hydroxy-Δ8-tetrahydrocannabinol structure, also known as dibenzopyrans, with further substitution on the 3-pentyl group by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkyethyl, 1-(n-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group;</p><p class="text-indent-4">"<span class="level-num">(xxxii)</span> Tetrahydrodibenzopyrans: Any compound containing or structurally derived from whether or not substituted in the tricyclic ring system except where contained in cannabis or cannabis resin;</p><p class="text-indent-4">"<span class="level-num">(xxxiii)</span> Tetramethylcyclopropanoylindoles: Any compound containing or structurally derived from 3-tetramethylcyclopropanoylindole, 3-(1 tetramethylcyclopropyl)indole, 3-(2,2,3,3-tetramethylcyclopropyl)indole or 3-(2,2,3,3-tetramethylcyclopropylcarbonyl)indole with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropanoyl ring to any extent. Tetramethylcyclopropanoylindoles include cyclopropoylindoles, any compound containing or structurally derived from a 3-(cyclopropoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl,1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,1-(N-methyl-2-pyrrolidinyl)methyl,1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the cyclopropoyl ring to any extent. Examples of tetramethylcyclopropanoylindoles include:</p><p class="text-indent-5">"<span class="level-num">(I)</span> A-796,260, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> [1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> A-796260;</p><p class="text-indent-5">"<span class="level-num">(II)</span> A-834,735, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> [1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> A-834735;</p><p class="text-indent-5">"<span class="level-num">(III)</span> AB-034 (also known as [1-[(N-methylpiperidin-2-yl)methyl]-1H-indole-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone);</p><p class="text-indent-5">"<span class="level-num">(IV)</span> UR-144 (also known as 1-pentyl-3-(2, 2, 3, 3-tetramethylcyclopropoyl)indole);</p><p class="text-indent-5">"<span class="level-num">(V)</span> 5-bromo-UR-144, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> ​[1-(5-bromopentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> UR-144 N-(5-bromopentyl) analog;</p><p class="text-indent-5">"<span class="level-num">(VI)</span> 5-chloro-UR-144, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 1-(5-chloropentyl)-3-(2, 2, 3, 3-tetramethylcyclopropoyl)indole; or</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 5Cl-UR-144; and</p><p class="text-indent-5">"<span class="level-num">(VII)</span> XLR11, also known as:</p><p class="text-indent-6">"<span class="level-num">(aa)</span> 1-(5-fluoropentyl)-3-(2,2,3, 3-tetramethylcyclopropoyl)indole;</p><p class="text-indent-6">"<span class="level-num">(bb)</span> 5-FUR-144; or</p><p class="text-indent-6">"<span class="level-num">(cc)</span> 5-fluoro UR-144;</p><p class="text-indent-4">"<span class="level-num">(xxxiv)</span> Tetramethylcyclopropane-Thiazole Carboxamides: Any compound containing or structurally derived from 2,2,3,3-tetramethyl-N-(thiazol-2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen atom of the thiazole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or not further substituted in the thiazole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent. Examples of tetramethylcyclopropane-thiazole carboxamides include the group tetramethylcyclopropyl thiazoles, or any compound containing or structurally derived from 2,2,3,3-tetramethyl-N-(thiazol- 2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen atom of the thiazole ring, whether or not further substituted in the thiazole ring to any extent, whether or not substituted in the tetramethylcyclopropyl ring to any extent. Tetramethylcyclopropane-thiazole carboxamides also include A-836,339, also known as:</p><p class="text-indent-5">"<span class="level-num">(I)</span> [N(Z)]-N-[3-(2-methoxyethyl)-4,5-dimethyl-2(3H)-thiazolylidene]-2,2,3,3-tetramethyl-cyclopropanecarboxamide;</p><p class="text-indent-5">"<span class="level-num">(II)</span> N-[3-(2-Methoxyethyl)-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene]-2,2,3,3-tetramethylcyclopropanecarboxamide: or</p><p class="text-indent-5">"<span class="level-num">(III)</span> A-836339;</p><p class="text-indent-3">"<span class="level-num">(B)</span> Unclassified Synthetic Cannabimimetic Agents:</p><p class="text-indent-4">"<span class="level-num">(i)</span> AM-356, also known as:</p><p class="text-indent-5">"<span class="level-num">(I)</span> AM356;</p><p class="text-indent-5">"<span class="level-num">(II)</span> arachidonyl-1'-hydroxy-2'-propylamide;</p><p class="text-indent-5">"<span class="level-num">(III)</span> N-(2-hydroxy-1R-methylethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide</p><p class="text-indent-5">"<span class="level-num">(IV)</span><span class="level-num">(R)</span> -(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide;</p><p class="text-indent-5">"<span class="level-num">(V)</span> Methanandamide; or</p><p class="text-indent-5">"<span class="level-num">(VI)</span> R-1 Methanandamide;</p><p class="text-indent-4">"<span class="level-num">(ii)</span> AM-855 (also known as (4aR,12bR)-8-hexyl-2,5,5-trimethyl-1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol);</p><p class="text-indent-4">"<span class="level-num">(iii)</span> AM-905 (also known as (6aR,9R,10aR)-3-[(E)-hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol);</p><p class="text-indent-4">"<span class="level-num">(iv)</span> AM-906 (also known as (6aR,9R,10aR)-3-[(Z)-hept-1-enyl]9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol);</p><p class="text-indent-4">"<span class="level-num">(v)</span> AM-2389 (also known as (6aR,9R,10aR)-3-(1-hexyl-cyclobut-1-yl) -6a,7,8,9,10,10a - hexahydro -6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9-diol);</p><p class="text-indent-4">"<span class="level-num">(vi)</span> BAY38-7271 (also known as (-)-(R)-3-(2-Hydroxymethylindanyl -4-oxy) phenyl-4,4,4-trifluorobutyl-1-sulfonate);</p><p class="text-indent-4">"<span class="level-num">(vii)</span> CP 50,556-1, also known as:</p><p class="text-indent-5">"<span class="level-num">(I)</span> 9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate;</p><p class="text-indent-5">"<span class="level-num">(II)</span> [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-; octahydrophenanthridin-1-yl] acetate;</p><p class="text-indent-5">"<span class="level-num">(III)</span> [9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10, 10a-octahydrophenanthridin-1-yl]acetate; or</p><p class="text-indent-5">"<span class="level-num">(IV)</span> "Levonantradol";</p><p class="text-indent-4">"<span class="level-num">(viii)</span> FUB-144  (also known as (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone);</p><p class="text-indent-4">"<span class="level-num">(ix)</span> FUB-AMB, also known as:</p><p class="text-indent-5">"<span class="level-num">(I)</span> AMB-FUBINACA; or</p><p class="text-indent-5">"<span class="level-num">(II)</span> Methyl (1-(4-fluorobenzyl)-1 H-indazole-3-carbonyl) valinate; and</p><p class="text-indent-4">"<span class="level-num">(x)</span> 5-fluoro-AMB (also known as (S)- methyl 2- (1- (5-fluoropentyl)- 1H- indazole- 3-carboxamido)- 3- methylbutanoate);</p><p class="text-indent-4">"<span class="level-num">(xi)</span> HU-308 (also known as (91R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol);</p><p class="text-indent-4">"<span class="level-num">(xii)</span> HU-331 (also known as 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione);</p><p class="text-indent-4">"<span class="level-num">(xiii)</span> JTE-907 (also known as N-(benzol[1,3]dioxol-5-ylmethyl) –7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide);</p><p class="text-indent-4">"<span class="level-num">(xiv)</span> JWH-057 (also known as (6aR,10aR)-3-(1,1-dimethylheptyl) -6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-Dibenzo[b,d]pyran);</p><p class="text-indent-4">"<span class="level-num">(xv)</span> Mepirapim (also known as (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl) Methanone);</p><p class="text-indent-4">"<span class="level-num">(xvi)</span> URB597 (also known as [3-(3-carbamoylphenyl)phenyl] –N-Cyclohexylcarbamate);</p><p class="text-indent-4">"<span class="level-num">(xvii)</span> URB602, also known as:</p><p class="text-indent-5">"<span class="level-num">(I)</span> [1,1'-Biphenyl]-3-yl-carbamic acid, cyclohexyl ester; or</p><p class="text-indent-5">"<span class="level-num">(II)</span> cyclohexyl [1,1'-biphenyl]-3-ylcarbamate;</p><p class="text-indent-4">"<span class="level-num">(xviii)</span> URB754 (also known as 6-methyl-2-[(4-methylphenyl)amino] -4H-3,1-benzoxazin-4-one);</p><p class="text-indent-4">"<span class="level-num">(xix)</span> URB937 (also known as 3'-carbamoyl-6-hydroxy-[1,1'-biphenyl]-3-yl Cyclohexylcarbamate);</p><p class="text-indent-4">"<span class="level-num">(xx)</span> SDB-006 (also known as N-benzyl-1-pentyl-1H-indole-3-carboxamide);</p><p class="text-indent-4">"<span class="level-num">(xxi)</span> THJ-2201 (also known as [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone); and</p><p class="text-indent-4">"<span class="level-num">(xxii)</span> THJ-018 (also known as Naphthalen-1-yl(1-pentyl-1H-indazol-3-yl)methanone).".</p><p class="text-indent-1"><span class="level-num">(c)</span> Section 208(a)(7) (D.C. Official Code § 48-902.08(a)(7)) is repealed.</p><p class="text-indent-1"><span class="level-num">Sec. 3. </span>Fiscal impact statement.</p><p class="text-indent-1">The Council adopts the fiscal impact statement of the Chief Financial Officer as the fiscal impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat. 2038; D.C. Official Code § 1-301.47a).</p><p class="text-indent-1"><span class="level-num">Sec. 4. </span>Effective date.</p><p class="text-indent-1"><span class="level-num">(a)</span> This act shall take effect following approval by the Mayor (or in the event of veto by the Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(1) of the District of Columbia Home Rule Act, approved December 24, 1973 (87 Stat. 813; D.C. Official Code § 1-206.02(c)(1)), and publication in the District of Columbia Register.</p><p class="text-indent-1"><span class="level-num">(b)</span> This act shall expire after 225 days of its having taken effect.</p></section></section>
      </div>
    </main>
    <footer>
      <section class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
      </section>
    </footer>
    <script type="text/javascript" src="/js/search.js"> </script>
  </body>
</html>
